|
EP2289549A3
(en)
|
1999-10-01 |
2011-06-15 |
Immunogen, Inc. |
Immunoconjugates for treating cancer
|
|
US6362217B2
(en)
|
2000-03-17 |
2002-03-26 |
Bristol-Myers Squibb Company |
Taxane anticancer agents
|
|
JP2004501143A
(ja)
|
2000-06-22 |
2004-01-15 |
ニトロメド インコーポレーテッド |
ニトロソ化およびニトロシル化タキサン、組成物および使用方法
|
|
US7351542B2
(en)
|
2002-05-20 |
2008-04-01 |
The Regents Of The University Of California |
Methods of modulating tubulin deacetylase activity
|
|
EP1530465B2
(en)
|
2002-06-26 |
2015-12-16 |
MediGene AG |
Method of producing a cationic liposomal preparation comprising a lipophilic compound
|
|
CN101039957A
(zh)
|
2003-05-16 |
2007-09-19 |
因特缪恩公司 |
合成的趋化因子受体配体及其使用方法
|
|
US7597884B2
(en)
|
2004-08-09 |
2009-10-06 |
Alios Biopharma, Inc. |
Hyperglycosylated polypeptide variants and methods of use
|
|
US8691780B2
(en)
|
2005-02-17 |
2014-04-08 |
The Board Of Trustees Of The Leland Stanford Junior University |
Txr1 and enhanced taxane sensitivity based on the modulation of a pathway mediated thereby
|
|
AU2007228984B2
(en)
|
2006-03-22 |
2012-05-03 |
Syncore Biotechnology Co., Ltd |
Treatment of triple receptor negative breast cancer
|
|
PL217731B1
(pl)
|
2006-06-01 |
2014-08-29 |
Tomasz Byrski |
Sposób wykrywania genetycznie uwarunkowanej obniżonej odpowiedzi na chemioterapię cytostatykiem taksanowym, zastosowanie mutacji założycielskiej oraz zestawu do wykrywania takiej odpowiedzi
|
|
EP2296645B1
(en)
|
2008-05-22 |
2014-11-19 |
Galera Therapeutics, LLC |
Combination antitumor therapy
|
|
WO2010005850A1
(en)
|
2008-07-08 |
2010-01-14 |
The J. David Gladstone Institutes |
Methods and compositions for modulating angiogenesis
|
|
CN102040570B
(zh)
*
|
2009-10-14 |
2014-07-30 |
江苏先声药物研究有限公司 |
硫代紫杉烷类衍生物及其制备方法和用途
|
|
US9181343B2
(en)
|
2012-07-19 |
2015-11-10 |
Redwood Bioscience Inc. |
Antibody specific for CD22 and methods of use thereof
|
|
WO2014074218A1
(en)
|
2012-11-12 |
2014-05-15 |
Redwood Bioscience, Inc. |
Compounds and methods for producing a conjugate
|
|
KR102332790B1
(ko)
|
2013-02-15 |
2021-12-01 |
더 리젠츠 오브 더 유니버시티 오브 캘리포니아 |
키메라 항원 수용체 및 이의 이용 방법
|
|
CN105358531B
(zh)
|
2013-03-14 |
2017-11-14 |
利兰-斯坦福大学初级学院的董事会 |
线粒体醛脱氢酶‑2调节剂和其使用方法
|
|
CA3178867A1
(en)
|
2013-11-27 |
2015-06-04 |
Redwood Bioscience, Inc. |
Hydrazinyl-pyrrolo compounds and methods for producing a conjugate
|
|
DK3107899T3
(da)
|
2014-02-19 |
2020-11-16 |
Aviv Therapeutics Inc |
Mitokondriel aldehyddehydrogenase 2 (aldh2)-bindende polycykliske amider og anvendelse deraf til cancerbehandling
|
|
KR20220025946A
(ko)
|
2014-03-21 |
2022-03-03 |
애브비 인코포레이티드 |
항-ｅｇｆｒ 항체 및 항체 약물 접합체
|
|
WO2017083637A1
(en)
|
2015-11-12 |
2017-05-18 |
The Board Of Trustees Of The Leland Stanford Junior University |
Cell-penetrating, guanidinium-rich oligophosphotriesters for drug and probe delivery
|
|
WO2017087723A1
(en)
|
2015-11-19 |
2017-05-26 |
The Regents Of The University Of California |
Conditionally repressible immune cell receptors and methods of use thereof
|
|
TWI760319B
(zh)
|
2015-12-30 |
2022-04-11 |
杏國新藥股份有限公司 |
乳癌治療
|
|
EP3231421A1
(en)
|
2016-04-11 |
2017-10-18 |
Greenaltech, S.L. |
Uses of a carotenoid in the treatment or prevention of stress induced conditions
|
|
KR20180135458A
(ko)
|
2016-04-26 |
2018-12-20 |
알.피.쉐러 테크놀러지즈 엘엘씨 |
항체 컨쥬게이트 및 이의 제조 및 이용 방법
|
|
JP7109427B2
(ja)
|
2016-06-01 |
2022-07-29 |
セルヴィエ アイピー ユーケー リミテッド |
ポリアルキレンオキシド－アスパラギナーゼの製剤ならびにその製造法および使用法
|
|
MX2018015272A
(es)
|
2016-06-08 |
2019-08-12 |
Abbvie Inc |
Anticuerpos anti-cd98 y conjugados de anticuerpo y farmaco.
|
|
TW202304996A
(zh)
|
2016-06-08 |
2023-02-01 |
美商艾伯維有限公司 |
抗-b7-h3抗體及抗體藥物結合物
|
|
EP3468598A1
(en)
|
2016-06-08 |
2019-04-17 |
AbbVie Inc. |
Anti-cd98 antibodies and antibody drug conjugates
|
|
MX2018015285A
(es)
|
2016-06-08 |
2019-09-18 |
Abbvie Inc |
Anticuerpos anti-b7-h3 y conjugados de anticuerpo y farmaco.
|
|
CN109563167A
(zh)
|
2016-06-08 |
2019-04-02 |
艾伯维公司 |
抗b7-h3抗体和抗体药物偶联物
|
|
TWI852903B
(zh)
|
2017-01-05 |
2024-08-21 |
杏國新藥股份有限公司 |
胰臟癌治療
|
|
AU2018211081B2
(en)
|
2017-01-18 |
2025-01-02 |
Bioatla, Inc. |
Chimeric antigen receptors against Axl or Ror2 and methods of use thereof
|
|
EP3388082A1
(en)
|
2017-04-13 |
2018-10-17 |
Galera Labs, LLC |
Combination cancer immunotherapy with pentaaza macrocyclic ring complex
|
|
CN111065623B9
(zh)
|
2017-05-24 |
2024-10-25 |
德克萨斯州大学系统董事会 |
用于抗体药物缀合物的接头
|
|
CN110003142A
(zh)
*
|
2018-01-04 |
2019-07-12 |
深圳福山生物科技有限公司 |
一种硒氰化合物及其用途
|
|
BR112020015520A2
(pt)
|
2018-01-31 |
2021-02-02 |
Galera Labs, Llc |
terapia de combinação para câncer com complexo de anel macrocíclico pentaaza e agente anticâncer à base de platina
|
|
US12090170B2
(en)
|
2018-04-06 |
2024-09-17 |
The Regents Of The University Of California |
Methods of treating glioblastomas
|
|
AU2019249215A1
(en)
|
2018-04-06 |
2020-10-22 |
The Regents Of The University Of California |
Methods of treating EGFRvIII expressing glioblastomas
|
|
BR112020020930A2
(pt)
|
2018-04-11 |
2021-03-02 |
Ohio State Innovation Foundation |
composição de liberação de fármaco, método para tratar um distúrbio oftalmológico e kit
|
|
MX2021000644A
(es)
|
2018-07-18 |
2021-08-19 |
Manzanita Pharmaceuticals Inc |
Conjugados para suministrar un agente contra el cancer a las celulas nerviosas, metodos de uso y metodos para la elaboracion de los mismos.
|
|
KR20220004653A
(ko)
|
2019-04-02 |
2022-01-11 |
켄조케티 바이오테크놀러지 인코포레이티드 |
유출 펌프-암 항원 다중특이적 항체 및 그것과 관련된 조성물, 시약, 키트 및 방법
|
|
JP2023512196A
(ja)
|
2020-01-29 |
2023-03-24 |
ケンジョッケティ バイオテクノロジー，インク． |
抗ｍｄｒ１抗体およびその使用
|
|
US20230192902A1
(en)
|
2020-06-04 |
2023-06-22 |
Kenjockety Biotechnology, Inc. |
Abcg2 efflux pump-cancer antigen multi-specific antibodies and compositions, reagents, kits and methods related thereto
|
|
CN116323662A
(zh)
|
2020-06-04 |
2023-06-23 |
肯乔克蒂生物技术股份有限公司 |
抗abcg2抗体及其用途
|
|
CN116490522A
(zh)
|
2020-09-02 |
2023-07-25 |
肯乔克蒂生物技术股份有限公司 |
抗abcc1抗体及其应用
|
|
CA3203652A1
(en)
|
2020-11-13 |
2022-05-19 |
William Robert ARATHOON |
Anti-mrp4 (encoded by abcc4 gene) antibodies and uses thereof
|
|
MX2023005979A
(es)
|
2020-11-20 |
2023-08-11 |
Scherer Technologies Llc R P |
Enlazadores de escisión doble de glicósido para conjugados de anticuerpo y fármaco.
|
|
UY39610A
(es)
|
2021-01-20 |
2022-08-31 |
Abbvie Inc |
Conjugados anticuerpo-fármaco anti-egfr
|
|
EP4448007A1
(en)
|
2021-12-13 |
2024-10-23 |
William Robert Arathoon Living Trust Dated August 29, 2016 |
Anti-abcb1 antibodies
|
|
WO2023159220A1
(en)
|
2022-02-18 |
2023-08-24 |
Kenjockety Biotechnology, Inc. |
Anti-cd47 antibodies
|